Aspirin for primary prevention of CVD in CKD: where do we stand?

Affiliations

¹ SW Thames Renal Unit, Epsom and St Helier NHS Trust, Renal Unit, St Helier Hospital, Carshalton, Sutton.
² Primary Care and Population Sciences, University of Southampton, Aldermoor Health Centre, Southampton.
³ Carmel Medical Practice, Darlington; Honorary Professor of Cardiology, School for Health, Durham University, Durham, Stockton-on-Tees.

Editorial

Hugh Gallagher et al. Br J Gen Pract. 2019.

. 2019 Nov 28;69(689):590-591.

doi: 10.3399/bjgp19X706661. Print 2019 Dec.

¹ SW Thames Renal Unit, Epsom and St Helier NHS Trust, Renal Unit, St Helier Hospital, Carshalton, Sutton.
² Primary Care and Population Sciences, University of Southampton, Aldermoor Health Centre, Southampton.
³ Carmel Medical Practice, Darlington; Honorary Professor of Cardiology, School for Health, Durham University, Durham, Stockton-on-Tees.

No abstract available

Comment on

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.
Antithrombotic Trialists' (ATT) Collaboration; Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, Buring J, Hennekens C, Kearney P, Meade T, Patrono C, Roncaglioni MC, Zanchetti A. Antithrombotic Trialists' (ATT) Collaboration, et al. Lancet. 2009 May 30;373(9678):1849-60. doi: 10.1016/S0140-6736(09)60503-1. Lancet. 2009. PMID: 19482214 Free PMC article.

1. Ng Fat L, Mindell JS, Roderick P. Health Survey for England 2016 kidney and liver disease. 2017. http://healthsurvey.hscic.gov.uk/media/63736/HSE2016-Adult-kid-liv.pdf (accessed 7 Nov 2019)
1. Chronic Kidney Disease Prognosis Consortium. Matsushita K, van der Velde M, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375(9731):2073–2081. - PMC - PubMed
1. Antithrombotic Trialists’ Collaboration Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324(7329):71–86. - PMC - PubMed
1. Antithrombotic Trialists’ (ATT) Collaboration. Baigent C, Blackwell L, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009;373(9678):1849–1860. - PMC - PubMed
1. The ASCEND Study Collaborative Group Effects of aspirin for primary prevention in persons with diabetes mellitus. New Engl J Med. 2018;379:1529–1539. - PubMed